Novel broad spectrum virucidal molecules against enveloped viruses

Area of Science:

• Virology
• Medicinal Chemistry
• Drug Discovery

Background:

• Viral infections pose a significant global health threat, with a notable lack of effective treatments for many viruses, especially emerging and re-emerging strains.
• The development of broad-spectrum antiviral agents is crucial for addressing this challenge and preparing for future viral outbreaks.

Purpose of the Study:

• To identify and characterize novel compounds with broad-spectrum antiviral activity.
• To evaluate the efficacy of rhodanine and thiobarbituric derivatives against a panel of enveloped viruses.

Main Methods:

• Synthesis and characterization of rhodanine and thiobarbituric derivatives.
• Antiviral screening against seven different enveloped viruses, including an acyclovir-resistant strain of herpes simplex virus type 2 (HSV-2).
• Determination of selectivity indexes to assess compound safety.

Main Results:

• A class of rhodanine and thiobarbituric derivatives demonstrated significant broad-spectrum antiviral activity.
• Compounds were effective against seven distinct enveloped viruses, including a resistant HSV-2 strain.
• Favorable selectivity indexes were observed, indicating a good safety profile.

Conclusions:

• Rhodanine and thiobarbituric derivatives represent a promising class of broad-spectrum antiviral compounds.
• The compounds' mechanism of action is hypothesized to involve disruption of the viral envelope's lipid bilayer, inhibiting virus-cell fusion.
• These findings support the potential development of these derivatives into novel antiviral therapies.